NBC News

Apricus Biosciences Expands Patent Coverage in Mexico for Its Erectile Dysfunction Drug, Vitaros(R)

SAN DIEGO, March 31, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI), announced today that the Mexican Patent Office ("MPO") will grant an additional patent for ...
Yahoo Finance

Apricus Biosciences Announces Outcome of Vitaros(TM) End-of-Review Meeting with FDA

SAN DIEGO, April 16, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced the outcome of ...
FierceBiotech

Apricus Biosciences Receives European Approval for Vitaros(R) for the Treatment of Erectile Dysfunction

Vitaros (R) is a topically-applied cream formulation of alprostadil, a vasodilator, combined with our proprietary permeation enhancer DDAIP.HCL, which directly increases blood flow to the penis, ...
National Institute for Health and Care Excellence

Key points from the evidence

In 2 randomised controlled trials (RCTs) alprostadil 300 microgram cream statistically significantly improved erectile function and intercourse ability compared with placebo but the average absolute ...
GEN

Ferring Buys Ex-U.S. Rights to Commercialize ED Cream from Apricus

Ferring Pharmaceuticals purchased ex-U.S. assets and rights to Apricus Biosciences’ on-demand topical erectile dysfunction therapy cream Vitaros ® (alprostadil) for potentially $12.7 million. Ferring ...
NBC News

Apricus Biosciences Will Request Approval of Vitaros(R) as a Treatment for Erectile Dysfunction in Switzerland, Based on Guidance From Swiss Regulatory Authorities

SAN DIEGO, May 19, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) announced today that it will file a marketing application in Switzerland for Vitaros ® as a ...
Medscape

Topical ED Treatment Vitaros Approved in Europe

Apricus Biosciences has received European approval to market alprostadil 0.3% topical cream (Vitaros) for the treatment of erectile dysfunction (ED), the company announced today. Vitaros is a ...
FierceBiotech

Apricus Biosciences Inc : Apricus and Laboratoires Majorelle Sign Exclusive License Agreement to Market Topical Erectile Dysfunction Cream Vitaros(R) in France, Monaco and ...

SAN DIEGO, Nov. 13, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus" or the "Company") (Nasdaq:APRI) (www.apricusbio.com), announced today that Apricus signed an exclusive license ...
Nature

Retention and migration of alprostadil cream applied topically to the glans meatus for erectile dysfunction

Retention and migration of a specially designed alprostadil transdermal cream was assessed after single-dose administration to the glans meatus of the penis. Seven men were enrolled in this two-way ...
Medscape

Alprostadil Cream May Be Effective Against Female Sexual Arousal Disorder

Oct. 20, 2005 (Montreal) — A transdermal cream formulation of alprostadil may be an effective treatment for female sexual arousal disorder (FSAD), according to phase 2 research. Alprostadil is a ...
Daily Mail

Woman suffers chemical burns after being mistakenly prescribed ERECTILE DYSFUNCTION cream called Vitaros instead of dry eye lubricant Vita-POS

A woman inadvertently put erectile dysfunction cream into her eye after a mix-up over two medications with very similar names. The patient, whose name and age are unknown, ended up with redness, ...